The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)May 29, 2025 — Research from the Lawrence Berkeley National Laboratory in California has revealed that solar electricity is poised to become the most cost-efficient source of energy in South Korea. According to a research team based at the lab, solar has the potential to have the lowest levelized cost of energy (LCOE) of all energy sources in South Korea by 2030 to 2035.
May 29, 2025 — Bitcoin hit an all-time high in the past week, surpassing the record it set back in January. The digital asset surged to $109,760.
May 29, 2025 — ONAR (OTCQB: ONAR) CEO Claude Zdanow appeared on the latest episode of IBN’s TechMediaWire Podcast to discuss the company’s mission to help middle-market businesses generate revenue through AI-powered marketing solutions. Zdanow explained ONAR’s two main verticals—Storia, focused on digital marketing, and Of Kos, which serves B2B healthcare clients—and how both leverage advanced technology to drive client growth.
May 28, 2025 — In the last year, Native American tribes have played an increasingly important role in the legal cannabis industry across the U. S.
May 28, 2025 — Lophora, a Danish biotech advancing next-generation psychedelic therapies, announced the first subjects have been dosed in its Phase 1 clinical trial of LPH-5, a novel serotonergic compound targeting central nervous system disorders. The trial, conducted by Biotrial in Rennes, France, is evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of both single and multiple ascending doses in healthy volunteers.
May 28, 2025 — TransCode Therapeutics (NASDAQ: RNAZ), has appointed Dr. Phillip D.
May 28, 2025 — Bioadaptives (BDPT), through its premium pet wellness division PawPa(TM), announced compelling clinical results for its flagship product Regen(TM) Dog Chews, formulated to naturally stimulate stem cell release and support canine vitality, mobility, and comfort. In veterinarian-led trials, Regen demonstrated a 281.
May 28, 2025 — Investing in clean technologies not only benefits the environment but also enhances operational efficiency and cost effectiveness. In its 2024 full-year and fourth-quarter financial results, Vivakor reported remarkable growth, with Q4 revenue increasing 201% YOY.
May 28, 2025 — Newton Golf reports three-figure revenue growth in first quarter of 2025. Newton Motion shaft adoption has surpassed 30 professionals.
May 28, 2025 — Lahontan Gold (TSX. V: LG) (OTCQB: LGCXF) has appointed IBN to manage its corporate communications as the company advances its gold and silver projects in Nevada’s Walker Lane district.
May 28, 2025 — TransCode Therapeutics (NASDAQ: RNAZ), has appointed Dr. Phillip D.
May 28, 2025 — Klarna’s CEO and co-founder, Sebastian Siemiatkowski, has acknowledged that the company’s heavy reliance on AI for customer support hasn’t gone as planned. Speaking at the company’s headquarters in Stockholm, he admitted that cutting costs had been too much of a priority, leading to a drop in service quality.
May 28, 2025 — The United States Senate has blocked a landmark California electric vehicle mandate that would have required the state to phase out gas-powered vehicles in favor of battery electric vehicles (BEVs). Although California already has the largest fleet of BEVs in the U.
May 28, 2025 — On May 22, the U. S.
May 28, 2025 — Gold ended this past week with strong gains as investors increasingly turned to safe-haven assets amid rising concerns about the reliability of the U. S.
May 28, 2025 — TransCode Therapeutics (NASDAQ: RNAZ), has appointed Dr. Phillip D.
May 28, 2025 — Subsidiary HOPE Therapeutics signed a $7. 8 million debt financing term sheet with Universal Capital.
May 28, 2025 — ONAR (OTCQB: ONAR), a marketing technology firm and agency network, will present at the Centurion One Capital 5th Annual LA Summit, set for June 5–6 at The Beverly Hills Hotel. Chairman and CEO Claude Zdanow is scheduled to speak at 1:50 p.
May 28, 2025 — Quantum BioPharma (NASDAQ: QNTM) has received human ethics review committee (HREC) approval in Australia to begin a Phase 2 clinical trial evaluating FSD202 for treating chronic widespread musculoskeletal nociplastic pain associated with idiopathic Mast Cell Activation Syndrome (MCAS). The randomized, double-blind, placebo-controlled trial will enroll 60 patients and measure pain reduction over 56 days.
May 28, 2025 — Brera Holdings (NASDAQ: BREA) announced that its affiliated Scottish club, Caledonia Braves, claimed the 2025 Fenix Trophy title with a 3-1 win over two-time champions FC United of Manchester. The final took place earlier this month at Lake Iseo, Italy, during the fourth edition of the tournament, which has earned recognition from UEFA and is dubbed the “Champions League for amateurs” by BBC Sport.